Screening for prostate cancer using prostate-specific antigen (PSA) tests with or without digital rectal exam does not significantly reduce prostate cancer deaths (even though it increases the likelihood of diagnosis). BMA says such tests should not be routine.
BMJ 2010;doi:10.1136/bmj.c4543
